Patients and HCP understanding on additonal monitoring

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/39273
• EU PAS number:
  EUPAS39272
• Study ID:
  39273
• Official title and acronym:
  Patients and HCP understanding on additonal monitoring
• DARWIN EU® study:
  No
• Study countries:
  Austria

  Belgium

  Bulgaria

  Cyprus

  Denmark

  Estonia

  Finland

  France

  Germany

  Greece

  Hungary

  Iceland

  Ireland

  Italy

  Latvia

  Liechtenstein

  Lithuania

  Luxembourg

  Netherlands

  Norway

  Portugal

  Romania

  Slovakia

  Slovenia

  Sweden

  United Kingdom
• Study description:
  The objective of this survey was to assess (a) attitudes towards ADR reporting and reasons for not reporting an ADR and (b) awareness of additional monitoring (AM) among health care professionals (HCPs), patients or their careers in EU countries
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 01/01/2017

Actual: 01/01/2017

Study start date

Planned: 01/09/2017

Actual: 01/09/2017

Date of final study report

Planned: 21/04/2020

Actual: 21/04/2020

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable